# Effectiveness and Safety of Combination Mifepristone/Misoprostol for Medical Abortion

> **NCT04905251** · — · TERMINATED · sponsor: **Linepharma International LTD** · enrollment: 129 (actual)

## Conditions studied

- Medical Abortion

## Interventions

- **DRUG:** Mifepristone-Misoprostol

## Key facts

- **NCT ID:** NCT04905251
- **Lead sponsor:** Linepharma International LTD
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2022-02-19
- **Primary completion:** 2024-02-20
- **Final completion:** 2024-02-20
- **Target enrollment:** 129 (ACTUAL)
- **Why stopped:** Insufficient Enrollment for Meaningful Analysis/Incomplete or Inconclusive Data Collection. Reaching desired participation numbers of subjects and site was determined to be unfeasible within the two year time period the study was intended to last.
- **Last updated:** 2025-02-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04905251

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04905251, "Effectiveness and Safety of Combination Mifepristone/Misoprostol for Medical Abortion". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04905251. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*